Activity of the EGFR-HER2 Dual Inhibitor Afatinib in EGFR-Mutant Lung Cancer Patients With Acquired Resistance to Reversible EGFR Tyrosine Kinase Inhibitors
Titel:
Activity of the EGFR-HER2 Dual Inhibitor Afatinib in EGFR-Mutant Lung Cancer Patients With Acquired Resistance to Reversible EGFR Tyrosine Kinase Inhibitors
Auteur:
Landi, Lorenza Tiseo, Marcello Chiari, Rita Ricciardi, Serena Rossi, Elisa Galetta, Domenico Novello, Silvia Milella, Michele D'Incecco, Armida Minuti, Gabriele Tibaldi, Carmelo Salvini, Jessica Facchinetti, Francesco Haspinger, Eva Regina Cortinovis, Diego Santo, Antonio Banna, Giuseppe Catino, Annamaria GiajLevra, Matteo Crinò, Lucio de Marinis, Filippo Cappuzzo, Federico